Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6350769rdf:typepubmed:Citationlld:pubmed
pubmed-article:6350769lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6350769lifeskim:mentionsumls-concept:C0000768lld:lifeskim
pubmed-article:6350769lifeskim:mentionsumls-concept:C0015392lld:lifeskim
pubmed-article:6350769lifeskim:mentionsumls-concept:C0007820lld:lifeskim
pubmed-article:6350769lifeskim:mentionsumls-concept:C0546881lld:lifeskim
pubmed-article:6350769pubmed:issue9lld:pubmed
pubmed-article:6350769pubmed:dateCreated1983-10-21lld:pubmed
pubmed-article:6350769pubmed:abstractTextTen patients with disequilibrium, ataxia, and cerebrovascular abnormalities were studied using computer aided eye tracking and vestibular function tests. The patients had severe abnormalities in smooth pursuit (decreased gain) and saccade tests (increased delay, decreased accuracy). Optokinetic responses were less affected. The gain of the vestibulo-oculomotor reflex was sometimes affected. Patients with eye tracking abnormalities frequently had symptoms of difficulty reading and watching television. When the lesion was asymmetrical, abnormal eye tracking tests usually pointed to the side of the lesion. Computer aided eye tracking tests are a useful adjunct to the evaluation of the patient with suspected vascular disease. They help to locate areas of central nervous system dysfunction, and produce an objective measurement of the severity of impairment. Conversely, when impairment of the smooth pursuit or saccade system is detected in patients being evaluated for disequilibrium, an assessment of the patients' cerebrovascular system should be considered.lld:pubmed
pubmed-article:6350769pubmed:languageenglld:pubmed
pubmed-article:6350769pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6350769pubmed:citationSubsetIMlld:pubmed
pubmed-article:6350769pubmed:statusMEDLINElld:pubmed
pubmed-article:6350769pubmed:monthSeplld:pubmed
pubmed-article:6350769pubmed:issn0023-852Xlld:pubmed
pubmed-article:6350769pubmed:authorpubmed-author:AndersonD RDRlld:pubmed
pubmed-article:6350769pubmed:authorpubmed-author:KonradH RHRlld:pubmed
pubmed-article:6350769pubmed:authorpubmed-author:RybakL PLPlld:pubmed
pubmed-article:6350769pubmed:authorpubmed-author:RamseyD EDElld:pubmed
pubmed-article:6350769pubmed:issnTypePrintlld:pubmed
pubmed-article:6350769pubmed:volume93lld:pubmed
pubmed-article:6350769pubmed:ownerNLMlld:pubmed
pubmed-article:6350769pubmed:authorsCompleteYlld:pubmed
pubmed-article:6350769pubmed:pagination1171-6lld:pubmed
pubmed-article:6350769pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6350769pubmed:meshHeadingpubmed-meshheading:6350769-...lld:pubmed
pubmed-article:6350769pubmed:meshHeadingpubmed-meshheading:6350769-...lld:pubmed
pubmed-article:6350769pubmed:meshHeadingpubmed-meshheading:6350769-...lld:pubmed
pubmed-article:6350769pubmed:meshHeadingpubmed-meshheading:6350769-...lld:pubmed
pubmed-article:6350769pubmed:meshHeadingpubmed-meshheading:6350769-...lld:pubmed
pubmed-article:6350769pubmed:meshHeadingpubmed-meshheading:6350769-...lld:pubmed
pubmed-article:6350769pubmed:meshHeadingpubmed-meshheading:6350769-...lld:pubmed
pubmed-article:6350769pubmed:meshHeadingpubmed-meshheading:6350769-...lld:pubmed
pubmed-article:6350769pubmed:meshHeadingpubmed-meshheading:6350769-...lld:pubmed
pubmed-article:6350769pubmed:meshHeadingpubmed-meshheading:6350769-...lld:pubmed
pubmed-article:6350769pubmed:meshHeadingpubmed-meshheading:6350769-...lld:pubmed
pubmed-article:6350769pubmed:meshHeadingpubmed-meshheading:6350769-...lld:pubmed
pubmed-article:6350769pubmed:meshHeadingpubmed-meshheading:6350769-...lld:pubmed
pubmed-article:6350769pubmed:year1983lld:pubmed
pubmed-article:6350769pubmed:articleTitleEye tracking abnormalities in patients with cerebrovascular disease.lld:pubmed
pubmed-article:6350769pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6350769pubmed:publicationTypeCase Reportslld:pubmed